The A-204C polymorphism in the cholesterol 7alpha-hydroxylase (CYP7A1) gene determines the cholesterolemia responsiveness to a high-fat diet

Physiol Res. 2004;53(5):565-8.

Abstract

The aim of the study was to ascertain whether the A-204C polymorphism in the cholesterol 7 -hydroxylase (CYP7A1) gene plays any role in determining LDL-cholesterol (LDL-C) concentration responsiveness to a high-fat diet. The concentrations of total cholesterol and LDL-cholesterol were measured in eleven healthy men (age: 30.9+/-3.2 years; BMI: 24.9+/-2.7 kg/m(2);;) who were homozygous for either the -204A or -204C allele, after 3 weeks on a low-fat (LF) diet and 3 weeks on a high-fat (HF) diet. During both dietary regimens, the isocaloric amount of food was provided to volunteers; LF diet contained 22 % of energy as a fat and 2.2 mg of cholesterol/kg of body weight a day, HF diet 40 % of fat and 9.7 mg of cholesterol/kg of body weight a day. In six subjects homozygous for the -204C allele, the concentrations of cholesterol and LDL-cholesterol were significantly higher on HF than on LF diet (cholesterol: 4.62 vs. 4.00 mmol/l, p<0.05; LDL-C: 2.15 vs. 1.63 mmol/l, p<0.01, respectively); no significant change was observed in five subjects homozygous for the -204A allele. There were no other differences in lipid and lipoprotein-lipid concentrations. Therefore, the polymorphism in the cholesterol 7alpha-hydroxylase promotor region seems to be involved in the determination of cholesterol and LDL-C responsiveness to a dietary fat challenge.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers / blood
  • Cholesterol 7-alpha-Hydroxylase / genetics*
  • Cholesterol, LDL / blood*
  • Cross-Over Studies
  • DNA Mutational Analysis
  • Diet Therapy / methods
  • Dietary Fats / metabolism*
  • Genetic Predisposition to Disease / genetics
  • Genetic Testing / methods
  • Humans
  • Hypercholesterolemia / blood*
  • Hypercholesterolemia / diet therapy
  • Hypercholesterolemia / enzymology*
  • Hypercholesterolemia / genetics
  • Male
  • Polymorphism, Genetic
  • Risk Assessment / methods*
  • Risk Factors
  • Treatment Outcome

Substances

  • Biomarkers
  • Cholesterol, LDL
  • Dietary Fats
  • Cholesterol 7-alpha-Hydroxylase